Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 178 entries
Sorted by: Best Match Show Resources per page
RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification

STEM and diversification

Beane JE, Brackney DE, Ebel GD.
GSID: 3sA5mfZ7fDcJ
DE Brackney, JE Beane, GD Ebel - PLoS pathogens, 2009 - journals.plos.org

… Notably, well documented imperfect stem-loops and other critical functional RNA structures within the 3′-UTR do not appear to be intensely targeted by the RNAi response. …

Cite
Brackney, D. E., Beane, J. E., & Ebel, G. D. (2009). RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS pathogens, 5(7), e1000502.
Brackney, Doug E., Jennifer E. Beane, and Gregory D. Ebel. "RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification." PLoS pathogens 5.7 (2009): e1000502.
Copy Download .nbib Format: MLA
Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone".

Journal of virology

Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Rückert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD.
PMID: 28356496
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.00172-17. Print 2017 Apr 15.

No abstract available.

Cite
Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, et al. Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone". J Virol. 2017;91(8)doi: 10.1128/JVI.00172-17.
Weger-Lucarelli, J., Duggal, N. K., Bullard-Feibelman, K., Veselinovic, M., Romo, H., Nguyen, C., Rückert, C., Brault, A. C., Bowen, R. A., Stenglein, M., Geiss, B. J., & Ebel, G. D. (2017). Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone". Journal of virology, 91(8), . https://doi.org/10.1128/JVI.00172-17
Weger-Lucarelli, James, et al. "Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone"." Journal of virology vol. 91,8 (2017). doi: https://doi.org/10.1128/JVI.00172-17
Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Rückert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD. Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone". J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.00172-17. Print 2017 Apr 15. PMID: 28356496; PMCID: PMC5375690.
Copy Download .nbib Format: NLM
The trajectory of gray matter development in Broca's area is abnormal in people who stutter.

Frontiers in human neuroscience

Beal DS, Lerch JP, Cameron B, Henderson R, Gracco VL, De Nil LF.
PMID: 25784869
Front Hum Neurosci. 2015 Mar 03;9:89. doi: 10.3389/fnhum.2015.00089. eCollection 2015.

The acquisition and mastery of speech-motor control requires years of practice spanning the course of development. People who stutter often perform poorly on speech-motor tasks thereby calling into question their ability to establish the stable neural motor programs required...

Cite
Beal DS, Lerch JP, Cameron B, et al. The trajectory of gray matter development in Broca's area is abnormal in people who stutter. Front Hum Neurosci. 2015;9:89doi: 10.3389/fnhum.2015.00089.
Beal, D. S., Lerch, J. P., Cameron, B., Henderson, R., Gracco, V. L., & De Nil, L. F. (2015). The trajectory of gray matter development in Broca's area is abnormal in people who stutter. Frontiers in human neuroscience, 989. https://doi.org/10.3389/fnhum.2015.00089
Beal, Deryk S, et al. "The trajectory of gray matter development in Broca's area is abnormal in people who stutter." Frontiers in human neuroscience vol. 9 (2015): 89. doi: https://doi.org/10.3389/fnhum.2015.00089
Beal DS, Lerch JP, Cameron B, Henderson R, Gracco VL, De Nil LF. The trajectory of gray matter development in Broca's area is abnormal in people who stutter. Front Hum Neurosci. 2015 Mar 03;9:89. doi: 10.3389/fnhum.2015.00089. eCollection 2015. PMID: 25784869; PMCID: PMC4347452.
Copy Download .nbib Format: NLM
Prevention of recurrent nephrolithiasis in adults.

Annals of internal medicine

Bell DS.
PMID: 25845007
Ann Intern Med. 2015 Apr 07;162(7):528. doi: 10.7326/L15-5074.

No abstract available.

Cite
Bell DS. Prevention of recurrent nephrolithiasis in adults. Ann Intern Med. 2015;162(7):528doi: 10.7326/L15-5074.
Bell, D. S. (2015). Prevention of recurrent nephrolithiasis in adults. Annals of internal medicine, 162(7), 528. https://doi.org/10.7326/L15-5074
Bell, David S H. "Prevention of recurrent nephrolithiasis in adults." Annals of internal medicine vol. 162,7 (2015): 528. doi: https://doi.org/10.7326/L15-5074
Bell DS. Prevention of recurrent nephrolithiasis in adults. Ann Intern Med. 2015 Apr 07;162(7):528. doi: 10.7326/L15-5074. PMID: 25845007.
Copy Download .nbib Format: NLM
Elasmobranch pericardial function. 1. Pericardial pressures are not always negative.

Fish physiology and biochemistry

Abel DC, Graham JB, Lowell WR, Shabetai R.
PMID: 24234596
Fish Physiol Biochem. 1986 May;1(2):75-83. doi: 10.1007/BF02290207.

Acute studies have led to the generalization that negative pericardial pressure is necessary for optimal cardiac function in elasmobranchs. We chronically instrumented horn sharks with pericardial catheters to test the hypothesis that ejection of pericardial fluid through the pericardioperitoneal...

Cite
Abel DC, Graham JB, Lowell WR, et al. Elasmobranch pericardial function. 1. Pericardial pressures are not always negative. Fish Physiol Biochem. 1986;1(2):75-83doi: 10.1007/BF02290207.
Abel, D. C., Graham, J. B., Lowell, W. R., & Shabetai, R. (1986). Elasmobranch pericardial function. 1. Pericardial pressures are not always negative. Fish physiology and biochemistry, 1(2), 75-83. https://doi.org/10.1007/BF02290207
Abel, D C, et al. "Elasmobranch pericardial function. 1. Pericardial pressures are not always negative." Fish physiology and biochemistry vol. 1,2 (1986): 75-83. doi: https://doi.org/10.1007/BF02290207
Abel DC, Graham JB, Lowell WR, Shabetai R. Elasmobranch pericardial function. 1. Pericardial pressures are not always negative. Fish Physiol Biochem. 1986 May;1(2):75-83. doi: 10.1007/BF02290207. PMID: 24234596.
Copy Download .nbib Format: NLM
Type 2 diabetes.

Annals of internal medicine

Bell DS.
PMID: 26280421
Ann Intern Med. 2015 Aug 18;163(4):322. doi: 10.7326/L15-5122.

No abstract available.

Cite
Bell DS. Type 2 diabetes. Ann Intern Med. 2015;163(4):322doi: 10.7326/L15-5122.
Bell, D. S. (2015). Type 2 diabetes. Annals of internal medicine, 163(4), 322. https://doi.org/10.7326/L15-5122
Bell, David S H. "Type 2 diabetes." Annals of internal medicine vol. 163,4 (2015): 322. doi: https://doi.org/10.7326/L15-5122
Bell DS. Type 2 diabetes. Ann Intern Med. 2015 Aug 18;163(4):322. doi: 10.7326/L15-5122. PMID: 26280421.
Copy Download .nbib Format: NLM
β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature.

Open heart

DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH.
PMID: 25821584
Open Heart. 2015 Mar 21;2(1):e000230. doi: 10.1136/openhrt-2014-000230. eCollection 2015.

β-Blockers (BBs) are an essential class of cardiovascular medications for reducing morbidity and mortality in patients with heart failure (HF). However, a large body of data indicates that BBs should not be used as first-line therapy for hypertension (HTN)....

Cite
DiNicolantonio JJ, Fares H, Niazi AK, et al. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart. 2015;2(1):e000230doi: 10.1136/openhrt-2014-000230.
DiNicolantonio, J. J., Fares, H., Niazi, A. K., Chatterjee, S., D'Ascenzo, F., Cerrato, E., Biondi-Zoccai, G., Lavie, C. J., Bell, D. S., & O'Keefe, J. H. (2015). β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open heart, 2(1), e000230. https://doi.org/10.1136/openhrt-2014-000230
DiNicolantonio, James J, et al. "β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature." Open heart vol. 2,1 (2015): e000230. doi: https://doi.org/10.1136/openhrt-2014-000230
DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart. 2015 Mar 21;2(1):e000230. doi: 10.1136/openhrt-2014-000230. eCollection 2015. PMID: 25821584; PMCID: PMC4371808.
Copy Download .nbib Format: NLM
Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient.

Case reports in endocrinology

Bell DS.
PMID: 25785209
Case Rep Endocrinol. 2015;2015:676191. doi: 10.1155/2015/676191. Epub 2015 Feb 16.

SGLT2 inhibitors are only approved for use in adults with type 2 diabetes. However, because SGLT2 inhibitors have a mechanism of action that does not require the presence of endogenous insulin, these drugs should also be efficacious in type...

Cite
Bell DS. Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient. Case Rep Endocrinol. 2015;2015:676191doi: 10.1155/2015/676191.
Bell, D. S. (2015). Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient. Case reports in endocrinology, 2015676191. https://doi.org/10.1155/2015/676191
Bell, David S H. "Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient." Case reports in endocrinology vol. 2015 (2015): 676191. doi: https://doi.org/10.1155/2015/676191
Bell DS. Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient. Case Rep Endocrinol. 2015;2015:676191. doi: 10.1155/2015/676191. Epub 2015 Feb 16. PMID: 25785209; PMCID: PMC4345240.
Copy Download .nbib Format: NLM
Primary structure of tRNA(val)(2) from brewer's yeast.

FEBS letters

Bonnet J, Ebel JP, Dirheimer G.
PMID: 11945865
FEBS Lett. 1971 Jul 01;15(4):286-290. doi: 10.1016/0014-5793(71)80639-7.

No abstract available.

Cite
Bonnet J, Ebel JP, Dirheimer G. Primary structure of tRNA(val)(2) from brewer's yeast. FEBS Lett. 1971;15(4):286-290doi: 10.1016/0014-5793(71)80639-7.
Bonnet, J., Ebel, J. P., & Dirheimer, G. (1971). Primary structure of tRNA(val)(2) from brewer's yeast. FEBS letters, 15(4), 286-290. https://doi.org/10.1016/0014-5793(71)80639-7
Bonnet, J, et al. "Primary structure of tRNA(val)(2) from brewer's yeast." FEBS letters vol. 15,4 (1971): 286-290. doi: https://doi.org/10.1016/0014-5793(71)80639-7
Bonnet J, Ebel JP, Dirheimer G. Primary structure of tRNA(val)(2) from brewer's yeast. FEBS Lett. 1971 Jul 01;15(4):286-290. doi: 10.1016/0014-5793(71)80639-7. PMID: 11945865.
Copy Download .nbib Format: NLM
The frequency of errors in the classification of individuals on the basis of fallible test scores.

Educational and psychological measurement

EBEL RL.
PMID: 18921419
Educ Psychol Meas. 1947;7(4):725-34. doi: 10.1177/001316444700700406.

No abstract available.

Cite
EBEL RL. The frequency of errors in the classification of individuals on the basis of fallible test scores. Educ Psychol Meas. 1947;7(4):725-34doi: 10.1177/001316444700700406.
EBEL, R. L. (1947). The frequency of errors in the classification of individuals on the basis of fallible test scores. Educational and psychological measurement, 7(4), 725-34. https://doi.org/10.1177/001316444700700406
EBEL, R L. "The frequency of errors in the classification of individuals on the basis of fallible test scores." Educational and psychological measurement vol. 7,4 (1947): 725-34. doi: https://doi.org/10.1177/001316444700700406
EBEL RL. The frequency of errors in the classification of individuals on the basis of fallible test scores. Educ Psychol Meas. 1947;7(4):725-34. doi: 10.1177/001316444700700406. PMID: 18921419.
Copy Download .nbib Format: NLM
Medical schools' problems.

Science (New York, N.Y.)

Ebel TA.
PMID: 17770481
Science. 1977 Oct 21;198(4314):250. doi: 10.1126/science.198.4314.250-a.

No abstract available.

Cite
Ebel TA. Medical schools' problems. Science. 1977;198(4314):250doi: 10.1126/science.198.4314.250-a.
Ebel, T. A. (1977). Medical schools' problems. Science (New York, N.Y.), 198(4314), 250. https://doi.org/10.1126/science.198.4314.250-a
Ebel, T A. "Medical schools' problems." Science (New York, N.Y.) vol. 198,4314 (1977): 250. doi: https://doi.org/10.1126/science.198.4314.250-a
Ebel TA. Medical schools' problems. Science. 1977 Oct 21;198(4314):250. doi: 10.1126/science.198.4314.250-a. PMID: 17770481.
Copy Download .nbib Format: NLM
Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Bell DS, Mayo MS.
PMID: 15251708
Endocr Pract. 1998 Nov-Dec;4(6):360-4. doi: 10.4158/EP.4.6.360.

OBJECTIVE: To investigate whether patients previously treated with insulin or sulfonylureas alone can be transferred to a combination of sulfonylureas and metformin therapy and realize a prolonged weight loss.METHODS: We conducted a retrospective review of medical records to identify...

Cite
Bell DS, Mayo MS. Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin. Endocr Pract. 1998;4(6):360-4doi: 10.4158/EP.4.6.360.
Bell, D. S., & Mayo, M. S. (1998). Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 4(6), 360-4. https://doi.org/10.4158/EP.4.6.360
Bell, D S, and Mayo, M S. "Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 4,6 (1998): 360-4. doi: https://doi.org/10.4158/EP.4.6.360
Bell DS, Mayo MS. Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin. Endocr Pract. 1998 Nov-Dec;4(6):360-4. doi: 10.4158/EP.4.6.360. PMID: 15251708.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 178 entries